CELEBRATING 25 YEARS OF JCO

Commentary

Stem-Cell Biology and Cancer Therapy: The More Things Change...

Samuel Hellman, Leslie Botnick, and Peter Mauch

JCO Feb 20 2008: 821–822. [Full Text] [PDF] [From JCO 1983]

EDITORIALS

Prostate-Specific Antigen (PSA) and PSA Velocity: Competitors or Collaborators in the Prediction of Curable and Clinically Significant Prostate Cancer

Anthony V. D'Amico

JCO Feb 20 2008: 823–824. [Full Text] [PDF]

Novel Strategies for the Treatment of Lung Cancer: Modulation of Eicosanoids

Michael G. Backlund, Joseph M. Amann, and David H. Johnson

JCO Feb 20 2008: 825–827. [Full Text] [PDF]

How Safe Is Sentinel Lymph Node Biopsy in Patients With Vulvar Cancer?

Charles F. Levenback

JCO Feb 20 2008: 828–829. [Full Text] [PDF]

Of Mice and (Wo)Men: Is This Any Way to Test a New Drug?

Tufia C. Haddad and Douglas Yee

JCO Feb 20 2008: 830–832. [Full Text] [PDF]

Insulin in the Adjuvant Breast Cancer Setting: A Novel Therapeutic Target for Lifestyle and Pharmacologic Interventions?

Pamela J. Goodwin

JCO Feb 20 2008: 833–834. [Full Text] [PDF]

ORIGINAL REPORTS
Genitourinary Cancer
	Long-Term Prediction of Prostate Cancer: Prostate-Specific Antigen (PSA) Velocity Is Predictive but Does Not Improve the Predictive Accuracy of a Single PSA Measurement 15 Years or More Before Cancer Diagnosis in a Large, Representative, Unscreened Population
	David Ulmert, Angel M. Serio, Matthew F. O'Brien, Charlotte Becker, James A. Eastham, Peter T. Scardino, Thomas Björk, Göran Berglund, Andrew J. Vickers, and Hans Lilja
	JCO Feb 20 2008: 835–841. [Abstract] [Full Text] [PDF]
	Inherited Variation in the Androgen Pathway Is Associated With the Efficacy of Androgen-Deprivation Therapy in Men With Prostate Cancer
	Robert W. Ross, William K. Oh, Wanling Xie, Mark Pomerantz, Mari Nakabayashi, Oliver Sartor, Mary-Ellen Taplin, Meredith M. Regan, Philip W. Kantoff, and Matthew Freedman
	JCO Feb 20 2008: 842–847. [Abstract] [Full Text] [PDF]

Thoracic Oncology
	Eicosanoid Modulation in Advanced Lung Cancer: Cyclooxygenase-2 Expression Is a Positive Predictive Factor for Celecoxib + Chemotherapy—Cancer and Leukemia Group B Trial 30203
	Martin J. Edelman, Dee Watson, Xiaofei Wang, Carl Morrison, Robert A. Kratzke, Scott Jewell, Lydia Hodgson, Ann M. Mauer, Ajeet Gajra, Gregory A. Masters, Michelle Bedor, Everett E. Vokes, and Mark J. Green
	JCO Feb 20 2008: 848–855. [Abstract] [Full Text] [PDF]
	VEGF Polymorphisms and Survival in Early-Stage Non–Small-Cell Lung Cancer
	Rebecca Suk Heist, Rihong Zhai, Geoffrey Liu, Wei Zhou, Xihong Lin, Li Su, Kofi Asomaning, Thomas J. Lynch, John C. Wain, and David C. Christiani
	JCO Feb 20 2008: 856–862. [Abstract] [Full Text] [PDF]
	Randomized Phase II Trial of Erlotinib or Standard Chemotherapy in Patients With Advanced Non–Small-Cell Lung Cancer and a Performance Status of 2
	Rogerio Lilenbaum, Rita Axelrod, Sachdev Thomas, Afshin Dowlati, Leonard Seigel, Donald Albert, Karsten Witt, and David Botkin
	JCO Feb 20 2008: 863–869. [Abstract] [Full Text] [PDF]
	Randomized Phase II Study of Carboplatin and Etoposide With or Without the bcl-2 Antisense Oligonucleotide Oblimersen for Extensive-Stage Small-Cell Lung Cancer: CALGB 30103
	Charles M. Rudin, Ravi Salgia, Xiaofei Wang, Lydia D. Hodgson, Gregory A. Masters, Mark Green, and Everett E. Vokes
	JCO Feb 20 2008: 870–876. [Abstract] [Full Text] [PDF]
	Non-Overlapping and Non–Cell-Type–Specific Gene Expression Signatures Predict Lung Cancer Survival
	Zhifu Sun, Dennis A. Wigle, and Ping Yang
	JCO Feb 20 2008: 877–883. [Abstract] [Full Text] [PDF]

Gynecologic Cancer
	Sentinel Node Dissection Is Safe in the Treatment of Early-Stage Vulvar Cancer
	Ate G.J. Van der Zee, Maaike H. Oonk, Joanne A. De Hullu, Anca C. Ansink, Ignace Vergote, René H. Verheijen, Angelo Maggioni, Katja N. Gaarenstroom, Peter J. Baldwin, Eleonore B. Van Dorst, Jacobus Van der Velden, Ralph H. Hermans, Hans van der Putten, Pierre Drouin, Achim Schneider, and Wim J. Sluiter
	JCO Feb 20 2008: 884–889. [Abstract] [Full Text] [PDF]
	Phase III Trial of Gemcitabine Compared With Pegylated Liposomal Doxorubicin in Progressive or Recurrent Ovarian Cancer
	Gabriella Ferrandina, Manuela Ludovisi, Domenica Lorusso, Sandro Pignata, Enrico Breda, Antonella Savarese, Pietro Del Medico, Laura Scaltriti, Dionyssios Katsaros, Domenico Priolo, and Giovanni Scambia
	JCO Feb 20 2008: 890–896. [Abstract] [Full Text] [PDF]

Breast Cancer
	Short Preoperative Treatment With Erlotinib Inhibits Tumor Cell Proliferation in Hormone Receptor–Positive Breast Cancers
	Marta Guix, Nara de Matos Granja, Ingrid Meszoely, Theresa B. Adkins, Bobbye M. Wieman, Kerek E. Frierson, Violeta Sanchez, Melinda E. Sanders, Ana M. Grau, Ingrid A. Mayer, Gary Pestano, Yu Shyr, Senthil Muthuswamy, Benjamin Calvo, Helen Krontiras, Ian E. Krop, Mark C. Kelley, and Carlos L. Arteaga
	JCO Feb 20 2008: 897–906. First published on Jan 7 2008; 10.1200/JCO.2007.13.5939. [Abstract] [Full Text] [PDF]
	Impact of a Mixed Strength and Endurance Exercise Intervention on Insulin Levels in Breast Cancer Survivors
	Jennifer A. Ligibel, Nancy Campbell, Ann Partridge, Wendy Y. Chen, Taylor Salinardi, Haiyan Chen, Kristie Adloff, Aparna Keshaviah, and Eric P. Winer
	JCO Feb 20 2008: 907–912. [Abstract] [Full Text] [PDF]

Pediatric Oncology
	Clinical Significance of MYCN Amplification and Ploidy in Favorable-Stage Neuroblastoma: A Report From the Children's Oncology Group
	Jennifer Schneiderman, Wendy B. London, Garrett M. Brodeur, Robert P. Castleberry, A. Thomas Look, and Susan L. Cohn
	JCO Feb 20 2008: 913–918. [Abstract] [Full Text] [PDF]
	Phase I Clinical Trial of Cilengitide in Children With Refractory Brain Tumors: Pediatric Brain Tumor Consortium Study PBTC-012
	Tobey J. MacDonald, Clinton F. Stewart, Mehmet Kocak, Stewart Goldman, Richard G. Ellenbogen, Peter Phillips, Deborah Lafond, Tina Young Poussaint, Mark W. Kieran, James M. Boyett, and Larry E. Kun
	JCO Feb 20 2008: 919–924. [Abstract] [Full Text] [PDF]

Cost Effectiveness
	Docetaxel in Combination With Doxorubicin and Cyclophosphamide As Adjuvant Treatment for Early Node-Positive Breast Cancer: A Cost-Effectiveness and Cost-Utility Analysis
	Sorrel E. Wolowacz, David A. Cameron, Helen C. Tate, and Adrian Bagust
	JCO Feb 20 2008: 925–933. [Abstract] [Full Text] [PDF]

Supportive Care and Quality of Life
	Post-Traumatic Stress Outcomes in Non-Hodgkin's Lymphoma Survivors
	Sophia K. Smith, Sheryl Zimmerman, Christianna S. Williams, John S. Preisser, and Elizabeth C. Clipp
	JCO Feb 20 2008: 934–941. [Abstract] [Full Text] [PDF]

Gastrointestinal Cancer
	Full-Dose Gemcitabine With Concurrent Radiation Therapy in Patients With Nonmetastatic Pancreatic Cancer: A Multicenter Phase II Trial
	William Small, Jr, Jordan Berlin, Gary M. Freedman, Theodore Lawrence, Mark S. Talamonti, Mary F. Mulcahy, A. Bapsi Chakravarthy, Andre A. Konski, Mark M. Zalupski, Philip A. Philip, Timothy J. Kinsella, Nipun B. Merchant, John P. Hoffman, Al B. Benson, Steven Nicol, Rong M. Xu, John F. Gill, and Cornelius J. McGinn
	JCO Feb 20 2008: 942–947. [Abstract] [Full Text] [PDF]

Genetic Testing for Cancer
	Perceptions of Cancer Risks and Predictors of Colon and Endometrial Cancer Screening in Women Undergoing Genetic Testing for Lynch Syndrome
	Donald W. Hadley, Jean F. Jenkins, Seth M. Steinberg, David Liewehr, Stephanie Moller, Jean C. Martin, Kathleen A. Calzone, Peter W. Soballe, and Ilan R. Kirsch
	JCO Feb 20 2008: 948–954. [Abstract] [Full Text] [PDF]

Melanoma
	Phase III Comparison of Vitespen, an Autologous Tumor-Derived Heat Shock Protein gp96 Peptide Complex Vaccine, With Physician's Choice of Treatment for Stage IV Melanoma: The C-100-21 Study Group
	Alessandro Testori, Jon Richards, Eric Whitman, G. Bruce Mann, Jose Lutzky, Luis Camacho, Giorgio Parmiani, Giulio Tosti, John M. Kirkwood, Axel Hoos, Lianng Yuh, Renu Gupta, and Pramod K. Srivastava
	JCO Feb 20 2008: 955–962. [Abstract] [Full Text] [PDF] [Publisher's Note]

Other Malignancies
	Indium-111–Pentetreotide Scintigraphy and Somatostatin Receptor Subtype 2 Expression: New Prognostic Factors for Malignant Well-Differentiated Endocrine Tumors
	Amani Asnacios, Frédéric Courbon, Philippe Rochaix, Eric Bauvin, Valérie Cances-Lauwers, Christiane Susini, Stefan Schulz, Andrée Boneu, Rosine Guimbaud, and Louis Buscail
	JCO Feb 20 2008: 963–970. [Abstract] [Full Text] [PDF]

REVIEW ARTICLE
	Neuroendocrine-Immune Mechanisms of Behavioral Comorbidities in Patients With Cancer
	Andrew H. Miller, Sonia Ancoli-Israel, Julienne E. Bower, Lucile Capuron, and Michael R. Irwin
	JCO Feb 20 2008: 971–982. [Abstract] [Full Text] [PDF]

SPECIAL ARTICLE
	Biomarkers of Response to Epidermal Growth Factor Receptor Inhibitors in Non–Small-Cell Lung Cancer Working Group: Standardization for Use in the Clinical Trial Setting
	David A. Eberhard, Giuseppe Giaccone, and Bruce E. Johnson
	JCO Feb 20 2008: 983–994. [Abstract] [Full Text] [PDF]

BIOLOGY OF NEOPLASIA
	Early Events in the Pathogenesis of Epithelial Ovarian Cancer
	Charles N. Landen, Jr, Michael J. Birrer, and Anil K. Sood
	JCO Feb 20 2008: 995–1005. First published on Jan 14 2008; 10.1200/JCO.2006.07.9970. [Abstract] [Full Text] [PDF]

DIAGNOSIS IN ONCOLOGY

Tumor Lysis Syndrome After Capecitabine Plus Cisplatin Treatment in Advanced Gastric Cancer

Hye-Suk Han, Sook Ryun Park, Sun Young Kim, Young Iee Park, Jong Seok Lee, Myeong-Cherl Kook, Il Ju Choi, Chan Gyoo Kim, Jong Reul Lee, Soo Jeong Cho, and Noe Kyeong Kim

JCO Feb 20 2008: 1006–1008. [Full Text] [PDF]

Recombinant Factor VIIa in the Management of Pulmonary Hemorrhage Associated With Metastatic Choriocarcinoma

Matthew J. Wheater, Graham M. Mead, Sandeep Bhandari, and Jonathan Fennell

JCO Feb 20 2008: 1008–1010. [Full Text] [PDF]

Cardiac Involvement at Presentation of Non–Small-Cell Lung Cancer

Katarzyna Sosvinska-Mielcarek, Elzbieta Senkus-Konefka, Jacek Jassem, Julia Kulczycka, Jaroslaw Jendrzejewski, and Kazimierz Jaskiewicz

JCO Feb 20 2008: 1010–1011. [Full Text] [PDF]

CORRESPONDENCE

Bevacizumab Plus Irinotecan in Recurrent Glioblastoma

Marc C. Chamberlain

JCO Feb 20 2008: 1012–1013. [Full Text] [PDF]

In Reply:

James J. Vredenburgh, Annick Desjardins, David A. Reardon, and Henry S. Friedman

JCO Feb 20 2008: 1013. [Full Text] [PDF]

Boost or Not

David A.L. Morgan and John F.R. Robertson

JCO Feb 20 2008: 1013-a–1014. [Full Text] [PDF]

In Reply:

Harry Bartelink, Jean-Claude Horiot, Philip Poortmans, and Laurence Collette

JCO Feb 20 2008: 1014. [Full Text] [PDF]

Patients With Breast Cancer Are Unlikely to Benefit From Prophylactic Irradiation of the Contralateral Breast

Riccardo Ponzone and Piero Sismondi

JCO Feb 20 2008: 1014-a–1015. [Full Text] [PDF]

In Reply:

David J. Brenner, Igor Shuryak, Sandra Russo, and Rainer K. Sachs

JCO Feb 20 2008: 1015–1016. [Full Text] [PDF]

Recurrent Priapism Related to Oxaliplatin Infusion

Antoine Adenis, Audrey Mailliez, Jean-Marc Rigot, Laurence Gamelin, Marie Vanhuyse, and Erick Gamelin

JCO Feb 20 2008: 1016–1017. [Full Text] [PDF]

ERRATA

ERRATUM

JCO Feb 20 2008: 1018. [Full Text] [PDF]

ERRATUM

JCO Feb 20 2008: 1018-a. [Full Text] [PDF]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.